Literature DB >> 27058935

Undertested and Overpriced: Japan Issues First Conditional Approval of Stem Cell Product.

Christopher McCabe1, Douglas Sipp2.   

Abstract

Mesh:

Year:  2016        PMID: 27058935     DOI: 10.1016/j.stem.2016.03.006

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  4 in total

Review 1.  Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations.

Authors:  Tamra Lysaght; Ian H Kerridge; Douglas Sipp; Gerard Porter; Benjamin J Capps
Journal:  J Bioeth Inq       Date:  2017-02-28       Impact factor: 1.352

2.  Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union.

Authors:  Yoji Jokura; Kazuo Yano; Masayuki Yamato
Journal:  J Tissue Eng Regen Med       Date:  2017-06-27       Impact factor: 3.963

3.  Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report.

Authors:  Amy L Ryan; Laertis Ikonomou; Sadaf Atarod; Deniz A Bölükbas; Jennifer Collins; Rob Freishtat; Finn Hawkins; Sarah E Gilpin; Franziska E Uhl; Juan Jose Uriarte; Daniel J Weiss; Darcy E Wagner
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 6.914

4.  Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.

Authors:  Sarah Chan
Journal:  Regen Med       Date:  2017-11-09       Impact factor: 3.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.